Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series B
Biotech
J&J, Google venture arms line up to back EpiBiologics' series B
Protein degradation biotech EpiBiologics brought in $107 million in a series B round headed up by J&J's and Google's respective venture arms.
James Waldron
Jan 8, 2026 9:05am
Series B round of $125M will fund Diagonal's move into clinic
Jan 8, 2026 6:30am
Fierce Biotech Fundraising Tracker: Syneron, Atavistik & more
Dec 19, 2025 2:00pm
Chai infuses AI drug discovery efforts with $130M series B
Dec 15, 2025 11:11am
Chinese biotech helmed by AZ veteran reels in $108M series B
Dec 10, 2025 3:45am
Triana crafts $120M series B to take glue degrader into clinic
Dec 3, 2025 10:35am
